Merck | MRK - Sales Revenues

Stock Price
116.20
Daily Change
-1.15 -0.98%
Monthly
-1.15%
Yearly
1.04%
Q2 Forecast
114.30

Merck reported EUR5.13B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Adidas EUR 6.59B 510M Mar/2026
Adyen EUR 1.42B 329.01M Dec/2025
Akzo Nobel EUR 2.39B 20M Mar/2026
Alcon AG USD 2.69B 10M Mar/2026
Amadeus IT EUR 1.68B 58.3M Mar/2026
Amarin USD 49.22M 451K Dec/2025
AstraZeneca USD 15.29B 213M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Beiersdorf EUR 2.48B 170M Mar/2026
Covestro EUR 2.92B 255M Dec/2025
Danone EUR 6.71B 170M Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.61B 460M Mar/2026
Genmab DKK 1.06B 36M Dec/2025
Givaudan CHF 3.61B 256M Dec/2025
GlaxoSmithKline GBP 7.63B 991M Mar/2026
GRIFOLS EUR 1.7B 280M Mar/2026
Henkel EUR 10.09B 4.93B Dec/2025
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Infineon EUR 3.81B 150M Mar/2026
Lakefront Biotherapeutics EUR 6.5M 894.32M Mar/2026
Linde USD 8.76B 149M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.13B 120M Mar/2026
Novartis USD 13.11B 226M Mar/2026
Philips EUR 3.91B 1.19B Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.24B 60M Mar/2026
UCB EUR 4.25B 764M Dec/2025